NEW YORK (Reuters Health) – Mounting evidence suggests that preoperative prostate specific antigen (PSA) kinetics are a poor marker of disease progression. During active surveillance for low-risk, low-volume…
NEW YORK (Reuters Health) – An iPhone with dedicated software for evaluation of coronary CT angiography (CTA) is highly accurate for detecting and excluding significant stenosis, according to…
NEW YORK (Reuters Health) – When colonoscopy is scheduled for the afternoon, drinking the electrolyte solution in the morning is clinically equivalent to drinking half of it the…
NEW YORK (Reuters Health) – Low-intensity extracorporeal shockwave therapy (LI-ESWT) can improve erectile function, according to a pilot study from Israel. Twice a week for 3 weeks, 20…
NEW YORK (Reuters Health) – Dizziness in the elderly is caused by cardiovascular disease in over half of patients seen in primary care, according to new research from…
NEW YORK (Reuters Health) – Pegylated interferon alfa-2a safely reduces HIV-1 load in untreated patients without chronic hepatitis C virus (HCV) infection, according to a report in the…
NEW YORK (Reuters Health) – Intravesical botulinum toxin improves overactive bladder symptoms, but with a significant risk of urinary retention, according to a meta-analysis reported April 19th in…
NEW YORK (Reuters Health) – Extracorporeal shock wave lithotripsy (ESWL) is an effective and safe treatment for renal calculi in children, French researchers report in the June issue…
NEW YORK (Reuters Health) – Biliary stenting can be an effective therapy for large or multiple common bile duct (CBD) stones, new research shows. With two months of…
NEW YORK (Reuters Health) – Long-term follow-up of more than 2000 patients with unprotected left main coronary artery disease shows stenting to be as effective as coronary artery…